

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of oxidative stress-induced neuron death (GO:1903203) | 6.24988559 |
| 2 | positive regulation of catecholamine secretion (GO:0033605) | 5.99934094 |
| 3 | response to muscle activity (GO:0014850) | 5.04802035 |
| 4 | regulation of autophagic vacuole assembly (GO:2000785) | 4.99295058 |
| 5 | regulation of vacuole organization (GO:0044088) | 4.68647226 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.53797487 |
| 7 | cellular response to zinc ion (GO:0071294) | 4.10757831 |
| 8 | regulation of oxidative phosphorylation (GO:0002082) | 4.09230528 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.06815779 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 4.03523073 |
| 11 | motile cilium assembly (GO:0044458) | 4.02116341 |
| 12 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.99031389 |
| 13 | * regulation of phosphoprotein phosphatase activity (GO:0043666) | 3.97793845 |
| 14 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.94344915 |
| 15 | T-helper cell differentiation (GO:0042093) | 3.89514375 |
| 16 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.89514375 |
| 17 | neuronal action potential (GO:0019228) | 3.88819900 |
| 18 | TOR signaling (GO:0031929) | 3.82268600 |
| 19 | multicellular organism reproduction (GO:0032504) | 3.80765547 |
| 20 | AMP metabolic process (GO:0046033) | 3.78979253 |
| 21 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.78328832 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.77251394 |
| 23 | cellular response to interleukin-15 (GO:0071350) | 3.76907442 |
| 24 | ADP metabolic process (GO:0046031) | 3.75037605 |
| 25 | activation of protein kinase A activity (GO:0034199) | 3.72956758 |
| 26 | mitochondrion degradation (GO:0000422) | 3.63777417 |
| 27 | synaptic vesicle exocytosis (GO:0016079) | 3.63176360 |
| 28 | coenzyme catabolic process (GO:0009109) | 3.61814019 |
| 29 | regulation of synapse structural plasticity (GO:0051823) | 3.60066404 |
| 30 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.59189089 |
| 31 | neuronal action potential propagation (GO:0019227) | 3.59140266 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.56636477 |
| 33 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56636477 |
| 34 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.52035948 |
| 35 | cellular response to toxic substance (GO:0097237) | 3.49857911 |
| 36 | locomotory exploration behavior (GO:0035641) | 3.49432813 |
| 37 | glutamate secretion (GO:0014047) | 3.44854828 |
| 38 | regulation of early endosome to late endosome transport (GO:2000641) | 3.43718052 |
| 39 | male meiosis (GO:0007140) | 3.40384416 |
| 40 | membrane depolarization during action potential (GO:0086010) | 3.39504206 |
| 41 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.39146852 |
| 42 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.39146852 |
| 43 | T cell differentiation involved in immune response (GO:0002292) | 3.39146852 |
| 44 | cell communication involved in cardiac conduction (GO:0086065) | 3.38135600 |
| 45 | actin-myosin filament sliding (GO:0033275) | 3.34609173 |
| 46 | muscle filament sliding (GO:0030049) | 3.34609173 |
| 47 | regulation of dopamine secretion (GO:0014059) | 3.32721994 |
| 48 | layer formation in cerebral cortex (GO:0021819) | 3.31336580 |
| 49 | plasma membrane repair (GO:0001778) | 3.30732664 |
| 50 | tolerance induction (GO:0002507) | 3.29501076 |
| 51 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.28958563 |
| 52 | vesicle transport along microtubule (GO:0047496) | 3.27841018 |
| 53 | cellular potassium ion homeostasis (GO:0030007) | 3.25766995 |
| 54 | regulation of cellular respiration (GO:0043457) | 3.25091645 |
| 55 | response to interleukin-15 (GO:0070672) | 3.24153747 |
| 56 | activation of protein kinase B activity (GO:0032148) | 3.23964222 |
| 57 | proline transport (GO:0015824) | 3.21611773 |
| 58 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.21494719 |
| 59 | regulation of synaptic vesicle transport (GO:1902803) | 3.21473797 |
| 60 | relaxation of smooth muscle (GO:0044557) | 3.21282512 |
| 61 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.19433818 |
| 62 | histone H3-K36 demethylation (GO:0070544) | 3.18891766 |
| 63 | dopamine receptor signaling pathway (GO:0007212) | 3.18450375 |
| 64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.14814163 |
| 65 | prepulse inhibition (GO:0060134) | 3.12397579 |
| 66 | membrane repolarization (GO:0086009) | 3.11132830 |
| 67 | muscle cell cellular homeostasis (GO:0046716) | 3.10843649 |
| 68 | regulation of germinal center formation (GO:0002634) | 3.10231882 |
| 69 | activated T cell proliferation (GO:0050798) | 3.08962828 |
| 70 | sodium ion export (GO:0071436) | 3.08218048 |
| 71 | acrosome reaction (GO:0007340) | 3.07484566 |
| 72 | peristalsis (GO:0030432) | 3.07032060 |
| 73 | urinary tract smooth muscle contraction (GO:0014848) | 3.05750572 |
| 74 | oligosaccharide biosynthetic process (GO:0009312) | 3.04533410 |
| 75 | myofibril assembly (GO:0030239) | 3.01283661 |
| 76 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.98935759 |
| 77 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.98543906 |
| 78 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97453963 |
| 79 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.96964754 |
| 80 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.96913206 |
| 81 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.96591185 |
| 82 | negative regulation of T cell mediated immunity (GO:0002710) | 2.95988993 |
| 83 | detection of calcium ion (GO:0005513) | 2.93582174 |
| 84 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.91987743 |
| 85 | positive regulation of granulocyte differentiation (GO:0030854) | 2.91950239 |
| 86 | negative regulation of cation channel activity (GO:2001258) | 2.91934032 |
| 87 | actin-mediated cell contraction (GO:0070252) | 2.91916635 |
| 88 | cell communication by electrical coupling (GO:0010644) | 2.91618667 |
| 89 | sperm motility (GO:0030317) | 2.91521604 |
| 90 | alpha-beta T cell differentiation (GO:0046632) | 2.90733078 |
| 91 | mating behavior (GO:0007617) | 2.89539377 |
| 92 | DNA double-strand break processing (GO:0000729) | 2.88737492 |
| 93 | vocalization behavior (GO:0071625) | 2.87212258 |
| 94 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.87092234 |
| 95 | cGMP-mediated signaling (GO:0019934) | 2.86110539 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85652167 |
| 97 | neuronal ion channel clustering (GO:0045161) | 2.85013197 |
| 98 | neurotransmitter secretion (GO:0007269) | 2.82522043 |
| 99 | striatum development (GO:0021756) | 2.82303294 |
| 100 | negative regulation of dendrite development (GO:2000171) | 2.81810573 |
| 101 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.81720664 |
| 102 | detection of temperature stimulus (GO:0016048) | 2.81395044 |
| 103 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.81155798 |
| 104 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.81155798 |
| 105 | positive regulation of potassium ion transport (GO:0043268) | 2.79349919 |
| 106 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.78779886 |
| 107 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.77873322 |
| 108 | protein maturation by protein folding (GO:0022417) | 2.77635456 |
| 109 | mast cell activation (GO:0045576) | 2.77267946 |
| 110 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.76877075 |
| 111 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.76877075 |
| 112 | neuromuscular process controlling balance (GO:0050885) | 2.76249607 |
| 113 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.76010577 |
| 114 | organelle transport along microtubule (GO:0072384) | 2.75660843 |
| 115 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.75471797 |
| 116 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.74112463 |
| 117 | cellular response to calcium ion (GO:0071277) | 2.72618522 |
| 118 | positive regulation of vesicle fusion (GO:0031340) | 2.72293320 |
| 119 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.72138206 |
| 120 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.71608523 |
| 121 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.71403639 |
| 122 | innervation (GO:0060384) | 2.70311111 |
| 123 | synaptic transmission, dopaminergic (GO:0001963) | 2.69353232 |
| 124 | protein K63-linked deubiquitination (GO:0070536) | 2.69295968 |
| 125 | negative T cell selection (GO:0043383) | 2.68301935 |
| 126 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.68217689 |
| 127 | positive regulation of muscle hypertrophy (GO:0014742) | 2.68217689 |
| 128 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.67446721 |
| 129 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.66752683 |
| 130 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.66547853 |
| 131 | potassium ion export (GO:0071435) | 2.66520804 |
| 132 | sarcomere organization (GO:0045214) | 2.65780790 |
| 133 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.65050937 |
| 134 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.63412451 |
| 135 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.63192618 |
| 136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.61690211 |
| 137 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.61211245 |
| 138 | protein targeting to plasma membrane (GO:0072661) | 2.60137645 |
| 139 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.59913057 |
| 140 | action potential (GO:0001508) | 2.59764673 |
| 141 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59555052 |
| 142 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.59412207 |
| 143 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.59092322 |
| 144 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.58675197 |
| 145 | positive regulation of glycolytic process (GO:0045821) | 2.57782130 |
| 146 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.56651988 |
| 147 | negative regulation of T cell apoptotic process (GO:0070233) | 2.56576837 |
| 148 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.56507914 |
| 149 | regulation of regulatory T cell differentiation (GO:0045589) | 2.56406557 |
| 150 | lymph node development (GO:0048535) | 2.56274387 |
| 151 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.55271730 |
| 152 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.54425457 |
| 153 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.53615154 |
| 154 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.52843257 |
| 155 | membrane budding (GO:0006900) | 2.51356869 |
| 156 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.51304721 |
| 157 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.50422836 |
| 158 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.50422836 |
| 159 | cellular sodium ion homeostasis (GO:0006883) | 2.50300675 |
| 160 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.50229889 |
| 161 | neuromuscular synaptic transmission (GO:0007274) | 2.50208062 |
| 162 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.50159415 |
| 163 | alpha-beta T cell activation (GO:0046631) | 2.49724033 |
| 164 | adenosine receptor signaling pathway (GO:0001973) | 2.49429298 |
| 165 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.49317461 |
| 166 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.49261632 |
| 167 | spermatid development (GO:0007286) | 2.48997049 |
| 168 | skeletal muscle contraction (GO:0003009) | 2.48732509 |
| 169 | regulation of membrane repolarization (GO:0060306) | 2.48520215 |
| 170 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.48305896 |
| 171 | T cell receptor signaling pathway (GO:0050852) | 2.48180517 |
| 172 | protein localization to endosome (GO:0036010) | 2.47272105 |
| 173 | T cell selection (GO:0045058) | 2.46436785 |
| 174 | reproduction (GO:0000003) | 2.46353849 |
| 175 | calcium ion-dependent exocytosis (GO:0017156) | 2.46111097 |
| 176 | exploration behavior (GO:0035640) | 2.45876959 |
| 177 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45502103 |
| 178 | regulation of myoblast differentiation (GO:0045661) | 2.45470573 |
| 179 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.45413319 |
| 180 | epithelial cilium movement (GO:0003351) | 2.45386623 |
| 181 | protein localization to synapse (GO:0035418) | 2.45239327 |
| 182 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.44848656 |
| 183 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44609729 |
| 184 | negative thymic T cell selection (GO:0045060) | 2.44425013 |
| 185 | axon cargo transport (GO:0008088) | 2.44337069 |
| 186 | potassium ion import (GO:0010107) | 2.43495749 |
| 187 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.43372348 |
| 188 | regulation of protein kinase A signaling (GO:0010738) | 2.43353572 |
| 189 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.43280516 |
| 190 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.42365319 |
| 191 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.41825310 |
| 192 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.41710764 |
| 193 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.41665606 |
| 194 | positive regulation of amine transport (GO:0051954) | 2.41652886 |
| 195 | T cell differentiation (GO:0030217) | 2.41519417 |
| 196 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.40702644 |
| 197 | tongue development (GO:0043586) | 2.40510582 |
| 198 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.40495168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.37547708 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 4.02237651 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.63108182 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.31845373 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.05584661 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94041119 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68442817 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66988012 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52989886 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.45512522 |
| 11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.34801653 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.33916950 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.33782533 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.33782533 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33659737 |
| 16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32979361 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27277517 |
| 18 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.23474259 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.23290683 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.21877038 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.16970175 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.14054843 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00971097 |
| 24 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.92257238 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.91210275 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89914500 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89056117 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88450452 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.82784297 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81990942 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81294881 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.80258772 |
| 33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79240460 |
| 34 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75354045 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.68631300 |
| 36 | * MYB_26560356_Chip-Seq_TH2_Human | 1.67087552 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.66852644 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.65601045 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.64270076 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.62067496 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61832647 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60423910 |
| 43 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59706750 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.58135970 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.57051306 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.56909597 |
| 47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56465071 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55914622 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55133782 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54947035 |
| 51 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.53964390 |
| 52 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.52380626 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.52175857 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.51881952 |
| 55 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51160825 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50522841 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50004438 |
| 58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.49928065 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48755461 |
| 60 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48630993 |
| 61 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46505725 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46425443 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46373567 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44637044 |
| 65 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.44123495 |
| 66 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.43803791 |
| 67 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42166953 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42083974 |
| 69 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.41625516 |
| 70 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.40750529 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.40750529 |
| 72 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40005285 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36004280 |
| 74 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35061993 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33150530 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32160240 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28157742 |
| 78 | * MYB_26560356_Chip-Seq_TH1_Human | 1.27794499 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27524191 |
| 80 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27060019 |
| 81 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25450018 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25239736 |
| 83 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23103186 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22782942 |
| 85 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22629169 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20848352 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20045430 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19688713 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19078202 |
| 90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18905621 |
| 91 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18455363 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17879126 |
| 93 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17037908 |
| 94 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.16791585 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16762894 |
| 96 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16162767 |
| 97 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15443858 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14368567 |
| 99 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13492205 |
| 100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12444249 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09773646 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08969264 |
| 103 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08592138 |
| 104 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07840172 |
| 105 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07803705 |
| 106 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07538479 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07486541 |
| 108 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.06233132 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06161404 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06051322 |
| 111 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05943846 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05664679 |
| 113 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04303772 |
| 114 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04303772 |
| 115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01729234 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99722362 |
| 117 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99029514 |
| 118 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98873430 |
| 119 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98568603 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98276737 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98246656 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96801647 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96766611 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96365658 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96104674 |
| 126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96062754 |
| 127 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95995574 |
| 128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.95658466 |
| 129 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95569093 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93905182 |
| 131 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93817345 |
| 132 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93780599 |
| 133 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92390022 |
| 134 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.92345070 |
| 135 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.91843315 |
| 136 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91481127 |
| 137 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.91063309 |
| 138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91041248 |
| 139 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90979918 |
| 140 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90821596 |
| 141 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90819683 |
| 142 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90610872 |
| 143 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.90420816 |
| 144 | TBL1_22424771_ChIP-Seq_293T_Human | 0.90177491 |
| 145 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89663938 |
| 146 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89180236 |
| 147 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89010396 |
| 148 | AR_19668381_ChIP-Seq_PC3_Human | 0.88543570 |
| 149 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.87642573 |
| 150 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87438357 |
| 151 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87405080 |
| 152 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87147414 |
| 153 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86757106 |
| 154 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86249604 |
| 155 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86115126 |
| 156 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86075877 |
| 157 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.86020069 |
| 158 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85825484 |
| 159 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85712971 |
| 160 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84732633 |
| 161 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84593020 |
| 162 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83841498 |
| 163 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.83841498 |
| 164 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.83221625 |
| 165 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83201477 |
| 166 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.83074695 |
| 167 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82902194 |
| 168 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.82641362 |
| 169 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82426952 |
| 170 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.81562203 |
| 171 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.81346885 |
| 172 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80696368 |
| 173 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.80332812 |
| 174 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80262175 |
| 175 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80137944 |
| 176 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80025687 |
| 177 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.79385857 |
| 178 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.79352162 |
| 179 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.79164131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 4.46378170 |
| 2 | MP0002735_abnormal_chemical_nociception | 4.02094034 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.92661271 |
| 4 | MP0004270_analgesia | 3.75688222 |
| 5 | MP0002736_abnormal_nociception_after | 3.58429220 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.43855844 |
| 7 | MP0008004_abnormal_stomach_pH | 3.31683420 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.26856849 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.04624751 |
| 10 | MP0002733_abnormal_thermal_nociception | 3.02160256 |
| 11 | MP0002822_catalepsy | 2.91814223 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.87896995 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.74244771 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.67888020 |
| 15 | MP0005410_abnormal_fertilization | 2.57341525 |
| 16 | MP0004858_abnormal_nervous_system | 2.55879549 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.55739482 |
| 18 | MP0005671_abnormal_response_to | 2.54723736 |
| 19 | MP0001970_abnormal_pain_threshold | 2.49601848 |
| 20 | MP0003315_abnormal_perineum_morphology | 2.45467977 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.44084270 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.42315457 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.28692025 |
| 24 | MP0003646_muscle_fatigue | 2.20442094 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.15995885 |
| 26 | MP0003724_increased_susceptibility_to | 2.11218214 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 2.08941553 |
| 28 | MP0004381_abnormal_hair_follicle | 2.03753855 |
| 29 | MP0001800_abnormal_humoral_immune | 1.98662571 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 1.97336824 |
| 31 | MP0002063_abnormal_learning/memory/cond | 1.96391756 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.96373554 |
| 33 | MP0002160_abnormal_reproductive_system | 1.95389213 |
| 34 | MP0000751_myopathy | 1.89741445 |
| 35 | MP0002272_abnormal_nervous_system | 1.88173299 |
| 36 | MP0009745_abnormal_behavioral_response | 1.87521300 |
| 37 | MP0002009_preneoplasia | 1.87336114 |
| 38 | MP0004272_abnormal_basement_membrane | 1.80119911 |
| 39 | MP0002132_abnormal_respiratory_system | 1.75052269 |
| 40 | MP0003880_abnormal_central_pattern | 1.73087102 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.71053699 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.70577824 |
| 43 | MP0003879_abnormal_hair_cell | 1.60201901 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.58744432 |
| 45 | MP0009785_altered_susceptibility_to | 1.58371476 |
| 46 | MP0002064_seizures | 1.57993232 |
| 47 | MP0003283_abnormal_digestive_organ | 1.57866786 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.56731898 |
| 49 | MP0001819_abnormal_immune_cell | 1.55832642 |
| 50 | MP0002723_abnormal_immune_serum | 1.54579956 |
| 51 | MP0005387_immune_system_phenotype | 1.54257861 |
| 52 | MP0001790_abnormal_immune_system | 1.54257861 |
| 53 | MP0009046_muscle_twitch | 1.53152261 |
| 54 | MP0005451_abnormal_body_composition | 1.50436994 |
| 55 | MP0002067_abnormal_sensory_capabilities | 1.49318495 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.45506149 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.44867295 |
| 58 | MP0005623_abnormal_meninges_morphology | 1.41635506 |
| 59 | MP0002572_abnormal_emotion/affect_behav | 1.41457956 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.41388875 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.36954552 |
| 62 | MP0004084_abnormal_cardiac_muscle | 1.36327130 |
| 63 | MP0002184_abnormal_innervation | 1.35717374 |
| 64 | MP0004036_abnormal_muscle_relaxation | 1.34644266 |
| 65 | MP0010368_abnormal_lymphatic_system | 1.33410987 |
| 66 | MP0004130_abnormal_muscle_cell | 1.33156677 |
| 67 | MP0001299_abnormal_eye_distance/ | 1.33134124 |
| 68 | MP0005389_reproductive_system_phenotype | 1.32947644 |
| 69 | MP0005360_urolithiasis | 1.31985161 |
| 70 | MP0003329_amyloid_beta_deposits | 1.30867424 |
| 71 | MP0000685_abnormal_immune_system | 1.29962990 |
| 72 | MP0004811_abnormal_neuron_physiology | 1.29725685 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 1.28892705 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 1.26023332 |
| 75 | MP0002398_abnormal_bone_marrow | 1.24026998 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.23634790 |
| 77 | MP0001919_abnormal_reproductive_system | 1.22122309 |
| 78 | MP0005330_cardiomyopathy | 1.21001594 |
| 79 | MP0000716_abnormal_immune_system | 1.20712168 |
| 80 | MP0001501_abnormal_sleep_pattern | 1.20706470 |
| 81 | MP0005275_abnormal_skin_tensile | 1.19393696 |
| 82 | MP0002102_abnormal_ear_morphology | 1.18773260 |
| 83 | MP0003436_decreased_susceptibility_to | 1.18329274 |
| 84 | MP0000747_muscle_weakness | 1.18263864 |
| 85 | MP0005166_decreased_susceptibility_to | 1.18034994 |
| 86 | MP0001984_abnormal_olfaction | 1.16945927 |
| 87 | MP0004085_abnormal_heartbeat | 1.16716837 |
| 88 | MP0003787_abnormal_imprinting | 1.16638250 |
| 89 | MP0005025_abnormal_response_to | 1.16393460 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 1.16345586 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 1.15774131 |
| 92 | MP0004484_altered_response_of | 1.14152802 |
| 93 | MP0003828_pulmonary_edema | 1.13874704 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 1.12290213 |
| 95 | MP0010155_abnormal_intestine_physiology | 1.12010077 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 1.11015147 |
| 97 | MP0002127_abnormal_cardiovascular_syste | 1.09373576 |
| 98 | MP0000534_abnormal_ureter_morphology | 1.07484705 |
| 99 | MP0002419_abnormal_innate_immunity | 1.06332822 |
| 100 | MP0002722_abnormal_immune_system | 1.05648247 |
| 101 | MP0005620_abnormal_muscle_contractility | 1.03101966 |
| 102 | MP0010386_abnormal_urinary_bladder | 1.01623789 |
| 103 | MP0001905_abnormal_dopamine_level | 1.00982068 |
| 104 | MP0001929_abnormal_gametogenesis | 1.00849467 |
| 105 | MP0001348_abnormal_lacrimal_gland | 1.00815524 |
| 106 | MP0001440_abnormal_grooming_behavior | 1.00448803 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.99762583 |
| 108 | MP0002972_abnormal_cardiac_muscle | 0.99635054 |
| 109 | MP0001873_stomach_inflammation | 0.99215323 |
| 110 | MP0001486_abnormal_startle_reflex | 0.99202284 |
| 111 | MP0004510_myositis | 0.99003289 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.98695714 |
| 113 | MP0000749_muscle_degeneration | 0.97807453 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.96757372 |
| 115 | MP0001664_abnormal_digestion | 0.96725901 |
| 116 | MP0003698_abnormal_male_reproductive | 0.96239078 |
| 117 | MP0001845_abnormal_inflammatory_respons | 0.95667832 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.94634682 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.93763165 |
| 120 | MP0002405_respiratory_system_inflammati | 0.93127540 |
| 121 | MP0000955_abnormal_spinal_cord | 0.92794689 |
| 122 | MP0003633_abnormal_nervous_system | 0.92449971 |
| 123 | MP0008569_lethality_at_weaning | 0.91699851 |
| 124 | MP0002277_abnormal_respiratory_mucosa | 0.89595594 |
| 125 | MP0004233_abnormal_muscle_weight | 0.89358889 |
| 126 | MP0000343_altered_response_to | 0.88683935 |
| 127 | MP0005187_abnormal_penis_morphology | 0.88423531 |
| 128 | MP0003075_altered_response_to | 0.87824319 |
| 129 | MP0001529_abnormal_vocalization | 0.86644865 |
| 130 | MP0003045_fibrosis | 0.86585728 |
| 131 | MP0002693_abnormal_pancreas_physiology | 0.85473698 |
| 132 | MP0005253_abnormal_eye_physiology | 0.85167999 |
| 133 | MP0002557_abnormal_social/conspecific_i | 0.84732212 |
| 134 | MP0004087_abnormal_muscle_fiber | 0.84098806 |
| 135 | MP0009697_abnormal_copulation | 0.83111410 |
| 136 | MP0004043_abnormal_pH_regulation | 0.82703530 |
| 137 | MP0005058_abnormal_lysosome_morphology | 0.82441620 |
| 138 | MP0003866_abnormal_defecation | 0.82011232 |
| 139 | MP0003183_abnormal_peptide_metabolism | 0.81049657 |
| 140 | MP0003656_abnormal_erythrocyte_physiolo | 0.80894700 |
| 141 | MP0001270_distended_abdomen | 0.80860067 |
| 142 | MP0003300_gastrointestinal_ulcer | 0.80302322 |
| 143 | MP0004924_abnormal_behavior | 0.79771914 |
| 144 | MP0005386_behavior/neurological_phenoty | 0.79771914 |
| 145 | MP0005266_abnormal_metabolism | 0.79360624 |
| 146 | MP0002751_abnormal_autonomic_nervous | 0.78432532 |
| 147 | MP0005647_abnormal_sex_gland | 0.77593763 |
| 148 | MP0000759_abnormal_skeletal_muscle | 0.77298157 |
| 149 | MP0002066_abnormal_motor_capabilities/c | 0.77029532 |
| 150 | MP0002429_abnormal_blood_cell | 0.76865926 |
| 151 | MP0002332_abnormal_exercise_endurance | 0.76810377 |
| 152 | MP0002882_abnormal_neuron_morphology | 0.76205535 |
| 153 | MP0002796_impaired_skin_barrier | 0.76169764 |
| 154 | MP0005369_muscle_phenotype | 0.74648114 |
| 155 | MP0002896_abnormal_bone_mineralization | 0.74552323 |
| 156 | MP0002876_abnormal_thyroid_physiology | 0.74006870 |
| 157 | MP0005499_abnormal_olfactory_system | 0.73600657 |
| 158 | MP0005394_taste/olfaction_phenotype | 0.73600657 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.73450052 |
| 160 | MP0006138_congestive_heart_failure | 0.73191423 |
| 161 | MP0008874_decreased_physiological_sensi | 0.72704335 |
| 162 | MP0005385_cardiovascular_system_phenoty | 0.69765921 |
| 163 | MP0001544_abnormal_cardiovascular_syste | 0.69765921 |
| 164 | MP0010771_integument_phenotype | 0.68512983 |
| 165 | MP0001188_hyperpigmentation | 0.67831105 |
| 166 | MP0005595_abnormal_vascular_smooth | 0.67801435 |
| 167 | MP0002269_muscular_atrophy | 0.65967769 |
| 168 | MP0001756_abnormal_urination | 0.64839339 |
| 169 | MP0003279_aneurysm | 0.64313130 |
| 170 | MP0008775_abnormal_heart_ventricle | 0.63412006 |
| 171 | MP0001958_emphysema | 0.62480575 |
| 172 | MP0005165_increased_susceptibility_to | 0.62395703 |
| 173 | MP0000750_abnormal_muscle_regeneration | 0.61215800 |
| 174 | MP0002106_abnormal_muscle_physiology | 0.60780426 |
| 175 | MP0005535_abnormal_body_temperature | 0.60474401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.87142749 |
| 2 | Eosinophilia (HP:0001880) | 4.55769586 |
| 3 | Reduced antithrombin III activity (HP:0001976) | 4.42525100 |
| 4 | Abnormality of the columella (HP:0009929) | 4.35890997 |
| 5 | Abnormality of eosinophils (HP:0001879) | 4.05701498 |
| 6 | Focal motor seizures (HP:0011153) | 4.03016461 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 3.85758271 |
| 8 | Rimmed vacuoles (HP:0003805) | 3.83477412 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.80261850 |
| 10 | Granulocytopenia (HP:0001913) | 3.74655688 |
| 11 | Clumsiness (HP:0002312) | 3.67078295 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.57366262 |
| 13 | Focal seizures (HP:0007359) | 3.51436761 |
| 14 | Visual hallucinations (HP:0002367) | 3.47977729 |
| 15 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.47926648 |
| 16 | Ulnar claw (HP:0001178) | 3.45113236 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 3.43447904 |
| 18 | Action tremor (HP:0002345) | 3.38084354 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 3.36144389 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.31163603 |
| 21 | Pheochromocytoma (HP:0002666) | 3.29074947 |
| 22 | Hypercortisolism (HP:0001578) | 3.25676349 |
| 23 | Stomatitis (HP:0010280) | 3.22044727 |
| 24 | T lymphocytopenia (HP:0005403) | 3.18366932 |
| 25 | Impaired pain sensation (HP:0007328) | 3.07557330 |
| 26 | Abnormality of pain sensation (HP:0010832) | 3.07557330 |
| 27 | Abnormality of the frontal sinuses (HP:0002687) | 3.03757049 |
| 28 | Abnormality of the calf musculature (HP:0001430) | 3.03108857 |
| 29 | Ankle clonus (HP:0011448) | 3.01165807 |
| 30 | IgG deficiency (HP:0004315) | 2.96229109 |
| 31 | Atonic seizures (HP:0010819) | 2.96095788 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.96066317 |
| 33 | Ventricular fibrillation (HP:0001663) | 2.93020500 |
| 34 | Neck muscle weakness (HP:0000467) | 2.88128955 |
| 35 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.87980456 |
| 36 | Dysautonomia (HP:0002459) | 2.87297236 |
| 37 | Annular pancreas (HP:0001734) | 2.86176015 |
| 38 | Neuroendocrine neoplasm (HP:0100634) | 2.86091688 |
| 39 | Myotonia (HP:0002486) | 2.85607174 |
| 40 | Myoglobinuria (HP:0002913) | 2.83830268 |
| 41 | Papilledema (HP:0001085) | 2.81348456 |
| 42 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.79976519 |
| 43 | Colitis (HP:0002583) | 2.77071435 |
| 44 | Rhabdomyolysis (HP:0003201) | 2.76139539 |
| 45 | Nemaline bodies (HP:0003798) | 2.73723820 |
| 46 | Scapular winging (HP:0003691) | 2.71899700 |
| 47 | Postural instability (HP:0002172) | 2.71313510 |
| 48 | Thyroiditis (HP:0100646) | 2.70598406 |
| 49 | Insidious onset (HP:0003587) | 2.69890872 |
| 50 | Termporal pattern (HP:0011008) | 2.69890872 |
| 51 | Leukocytosis (HP:0001974) | 2.69038065 |
| 52 | Distal arthrogryposis (HP:0005684) | 2.68808526 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.64103831 |
| 54 | Autoimmune hemolytic anemia (HP:0001890) | 2.59930123 |
| 55 | Absence seizures (HP:0002121) | 2.56611601 |
| 56 | Frequent falls (HP:0002359) | 2.55887920 |
| 57 | Sudden death (HP:0001699) | 2.52659729 |
| 58 | Abnormal ciliary motility (HP:0012262) | 2.50674281 |
| 59 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.48930080 |
| 60 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.47891275 |
| 61 | Depression (HP:0000716) | 2.46738018 |
| 62 | Hyporeflexia of lower limbs (HP:0002600) | 2.46199383 |
| 63 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.42738488 |
| 64 | Resting tremor (HP:0002322) | 2.40414165 |
| 65 | Abnormality of T cells (HP:0002843) | 2.39980048 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.39804361 |
| 67 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.39804361 |
| 68 | Difficulty climbing stairs (HP:0003551) | 2.39237344 |
| 69 | Type II lissencephaly (HP:0007260) | 2.37534236 |
| 70 | Rapidly progressive (HP:0003678) | 2.35789186 |
| 71 | Severe combined immunodeficiency (HP:0004430) | 2.34013897 |
| 72 | Gastrointestinal inflammation (HP:0004386) | 2.32409839 |
| 73 | Hypoplasia of the uterus (HP:0000013) | 2.31157406 |
| 74 | Hypothermia (HP:0002045) | 2.31013801 |
| 75 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.30158834 |
| 76 | Hammertoe (HP:0001765) | 2.27337805 |
| 77 | Bundle branch block (HP:0011710) | 2.26990175 |
| 78 | Gonadal dysgenesis (HP:0000133) | 2.26832297 |
| 79 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.26766805 |
| 80 | Absent/shortened dynein arms (HP:0200106) | 2.26766805 |
| 81 | Chronic sinusitis (HP:0011109) | 2.26638191 |
| 82 | Dialeptic seizures (HP:0011146) | 2.22671456 |
| 83 | Protruding tongue (HP:0010808) | 2.22086173 |
| 84 | Cerebellar dysplasia (HP:0007033) | 2.21392411 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.20728133 |
| 86 | Sensory axonal neuropathy (HP:0003390) | 2.20525219 |
| 87 | Generalized tonic-clonic seizures (HP:0002069) | 2.20022170 |
| 88 | Muscular dystrophy (HP:0003560) | 2.18938211 |
| 89 | Supranuclear gaze palsy (HP:0000605) | 2.18177073 |
| 90 | Myopathic facies (HP:0002058) | 2.17479735 |
| 91 | Proximal amyotrophy (HP:0007126) | 2.16838366 |
| 92 | Hypoventilation (HP:0002791) | 2.16488038 |
| 93 | Inability to walk (HP:0002540) | 2.15289458 |
| 94 | Difficulty running (HP:0009046) | 2.14132177 |
| 95 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.13916420 |
| 96 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.13916420 |
| 97 | Abnormal sex determination (HP:0012244) | 2.13345218 |
| 98 | Sex reversal (HP:0012245) | 2.13345218 |
| 99 | Increased variability in muscle fiber diameter (HP:0003557) | 2.13220260 |
| 100 | Anxiety (HP:0000739) | 2.13074107 |
| 101 | Torticollis (HP:0000473) | 2.11561331 |
| 102 | Muscle fiber splitting (HP:0003555) | 2.11215994 |
| 103 | Bulbar palsy (HP:0001283) | 2.10769913 |
| 104 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08933697 |
| 105 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08546466 |
| 106 | Distal upper limb amyotrophy (HP:0007149) | 2.07480016 |
| 107 | Upper limb amyotrophy (HP:0009129) | 2.07480016 |
| 108 | Failure to thrive in infancy (HP:0001531) | 2.06517436 |
| 109 | Polyneuropathy (HP:0001271) | 2.06001666 |
| 110 | Prolonged QT interval (HP:0001657) | 2.05632095 |
| 111 | Febrile seizures (HP:0002373) | 2.05181661 |
| 112 | Thoracic kyphosis (HP:0002942) | 2.04770898 |
| 113 | Amblyopia (HP:0000646) | 2.03026414 |
| 114 | Foot dorsiflexor weakness (HP:0009027) | 2.01561041 |
| 115 | Bronchiectasis (HP:0002110) | 2.01454849 |
| 116 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.00971595 |
| 117 | Progressive cerebellar ataxia (HP:0002073) | 2.00530657 |
| 118 | Abnormality of the vocal cords (HP:0008777) | 2.00390302 |
| 119 | Urinary urgency (HP:0000012) | 1.99986919 |
| 120 | Deep palmar crease (HP:0006191) | 1.99162112 |
| 121 | Areflexia of lower limbs (HP:0002522) | 1.98819180 |
| 122 | Megalencephaly (HP:0001355) | 1.98607323 |
| 123 | Growth hormone excess (HP:0000845) | 1.98391170 |
| 124 | Cerebral aneurysm (HP:0004944) | 1.97028676 |
| 125 | Recurrent sinusitis (HP:0011108) | 1.96529960 |
| 126 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.96330859 |
| 127 | Limb dystonia (HP:0002451) | 1.95202197 |
| 128 | Abnormality of the lower motor neuron (HP:0002366) | 1.94694133 |
| 129 | Adrenal overactivity (HP:0002717) | 1.93972122 |
| 130 | Rhinitis (HP:0012384) | 1.93848143 |
| 131 | Hypoproteinemia (HP:0003075) | 1.93745475 |
| 132 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92466666 |
| 133 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92466666 |
| 134 | Abnormal protein glycosylation (HP:0012346) | 1.92466666 |
| 135 | Abnormal glycosylation (HP:0012345) | 1.92466666 |
| 136 | Optic neuritis (HP:0100653) | 1.91610108 |
| 137 | Retrobulbar optic neuritis (HP:0100654) | 1.91610108 |
| 138 | B lymphocytopenia (HP:0010976) | 1.91068850 |
| 139 | Lower limb asymmetry (HP:0100559) | 1.91040218 |
| 140 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.90372889 |
| 141 | Buphthalmos (HP:0000557) | 1.90204656 |
| 142 | Cerebral hemorrhage (HP:0001342) | 1.89122195 |
| 143 | Palpitations (HP:0001962) | 1.88719728 |
| 144 | Potter facies (HP:0002009) | 1.88256619 |
| 145 | Facial shape deformation (HP:0011334) | 1.88256619 |
| 146 | Male pseudohermaphroditism (HP:0000037) | 1.88233963 |
| 147 | Vasculitis (HP:0002633) | 1.88227082 |
| 148 | Recurrent bronchitis (HP:0002837) | 1.87055393 |
| 149 | Exercise-induced myalgia (HP:0003738) | 1.86873198 |
| 150 | Postural tremor (HP:0002174) | 1.86134474 |
| 151 | Weak cry (HP:0001612) | 1.85939653 |
| 152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.85802089 |
| 153 | Increased IgM level (HP:0003496) | 1.85419253 |
| 154 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85125963 |
| 155 | Distal sensory impairment (HP:0002936) | 1.84874555 |
| 156 | Truncal ataxia (HP:0002078) | 1.84736912 |
| 157 | Abnormality of the foot musculature (HP:0001436) | 1.84070643 |
| 158 | Absent speech (HP:0001344) | 1.83994056 |
| 159 | Vertebral arch anomaly (HP:0008438) | 1.83852819 |
| 160 | Unsteady gait (HP:0002317) | 1.83741126 |
| 161 | Abnormal EKG (HP:0003115) | 1.83440089 |
| 162 | Facial diplegia (HP:0001349) | 1.82958777 |
| 163 | Bradycardia (HP:0001662) | 1.82936172 |
| 164 | Steppage gait (HP:0003376) | 1.81109026 |
| 165 | Poor eye contact (HP:0000817) | 1.80772521 |
| 166 | Thoracolumbar scoliosis (HP:0002944) | 1.79606338 |
| 167 | Shoulder girdle muscle weakness (HP:0003547) | 1.79018728 |
| 168 | Hand muscle atrophy (HP:0009130) | 1.78537483 |
| 169 | Hematochezia (HP:0002573) | 1.78462066 |
| 170 | Exercise-induced muscle cramps (HP:0003710) | 1.77641508 |
| 171 | Ankyloglossia (HP:0010296) | 1.77029770 |
| 172 | Impaired social interactions (HP:0000735) | 1.76702943 |
| 173 | Abnormal social behavior (HP:0012433) | 1.76702943 |
| 174 | Increased connective tissue (HP:0009025) | 1.76656027 |
| 175 | Menstrual irregularities (HP:0000858) | 1.76628623 |
| 176 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.73296760 |
| 177 | Focal dystonia (HP:0004373) | 1.72368618 |
| 178 | Neoplasm of the heart (HP:0100544) | 1.72145986 |
| 179 | Onion bulb formation (HP:0003383) | 1.71918867 |
| 180 | Bronchomalacia (HP:0002780) | 1.69999740 |
| 181 | Craniofacial dystonia (HP:0012179) | 1.69887610 |
| 182 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.68499029 |
| 183 | Achilles tendon contracture (HP:0001771) | 1.68470041 |
| 184 | Atrioventricular block (HP:0001678) | 1.68159540 |
| 185 | Hyperparathyroidism (HP:0000843) | 1.67794086 |
| 186 | Testicular atrophy (HP:0000029) | 1.65749436 |
| 187 | Retinal dysplasia (HP:0007973) | 1.65005259 |
| 188 | Long toe (HP:0010511) | 1.65002001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.71486384 |
| 2 | MAP3K9 | 4.11775551 |
| 3 | KSR2 | 3.77657870 |
| 4 | NTRK3 | 3.49995945 |
| 5 | NTRK1 | 3.23531816 |
| 6 | TLK1 | 3.05304405 |
| 7 | MAP3K2 | 2.97847047 |
| 8 | EPHA4 | 2.74944975 |
| 9 | PRKD3 | 2.66576177 |
| 10 | ARAF | 2.49062498 |
| 11 | MINK1 | 2.37478712 |
| 12 | TXK | 2.32024366 |
| 13 | RIPK4 | 2.23723363 |
| 14 | TRIB3 | 2.02436027 |
| 15 | FER | 2.00343988 |
| 16 | TIE1 | 1.92645201 |
| 17 | CAMKK2 | 1.83627949 |
| 18 | LMTK2 | 1.77410293 |
| 19 | MAP3K12 | 1.75930493 |
| 20 | LATS1 | 1.73098273 |
| 21 | EIF2AK3 | 1.71098743 |
| 22 | LATS2 | 1.66951691 |
| 23 | RET | 1.63780497 |
| 24 | BMPR2 | 1.63213326 |
| 25 | SCYL2 | 1.61062141 |
| 26 | GRK5 | 1.59922872 |
| 27 | CAMKK1 | 1.59673168 |
| 28 | PAK6 | 1.55293178 |
| 29 | NEK1 | 1.53981276 |
| 30 | ZAK | 1.53922720 |
| 31 | MAP3K1 | 1.53206944 |
| 32 | MYLK | 1.47328394 |
| 33 | STK38L | 1.46687458 |
| 34 | DAPK2 | 1.46345460 |
| 35 | DDR2 | 1.46022048 |
| 36 | NLK | 1.41201880 |
| 37 | PHKG1 | 1.35912544 |
| 38 | PHKG2 | 1.35912544 |
| 39 | MAP2K1 | 1.34368216 |
| 40 | KSR1 | 1.33502909 |
| 41 | FRK | 1.33240150 |
| 42 | MAP3K4 | 1.30959334 |
| 43 | CSNK1A1L | 1.30409730 |
| 44 | MAP2K4 | 1.28820921 |
| 45 | BTK | 1.27777996 |
| 46 | GRK6 | 1.27744596 |
| 47 | MST4 | 1.27178838 |
| 48 | RPS6KA5 | 1.26534099 |
| 49 | PDK3 | 1.24384301 |
| 50 | PDK4 | 1.24384301 |
| 51 | PIK3CA | 1.23625261 |
| 52 | PTK2B | 1.22105927 |
| 53 | PRKCQ | 1.21178912 |
| 54 | LIMK1 | 1.21097774 |
| 55 | RIPK1 | 1.19464472 |
| 56 | PDGFRA | 1.17015076 |
| 57 | CSNK1G3 | 1.16898692 |
| 58 | NEK2 | 1.14152109 |
| 59 | MAPKAPK3 | 1.12760471 |
| 60 | MAPK12 | 1.11642930 |
| 61 | ERBB3 | 1.10509234 |
| 62 | TAOK1 | 1.10221026 |
| 63 | MAP4K1 | 1.07436452 |
| 64 | PDK2 | 1.04063306 |
| 65 | PINK1 | 1.03734040 |
| 66 | KDR | 1.00550532 |
| 67 | BRAF | 0.99531120 |
| 68 | PTK2 | 0.98532642 |
| 69 | RPS6KA4 | 0.98501370 |
| 70 | WNK4 | 0.97440119 |
| 71 | PAK3 | 0.96482813 |
| 72 | CDK3 | 0.96349585 |
| 73 | * CDK5 | 0.95959873 |
| 74 | IKBKE | 0.95442624 |
| 75 | MAP2K2 | 0.94476563 |
| 76 | CSNK1G2 | 0.94212459 |
| 77 | TRPM7 | 0.93892713 |
| 78 | CSNK1G1 | 0.93479576 |
| 79 | TESK1 | 0.91283569 |
| 80 | SGK2 | 0.91042270 |
| 81 | SIK3 | 0.90056907 |
| 82 | PDPK1 | 0.85852002 |
| 83 | TAOK3 | 0.84184039 |
| 84 | MAP3K13 | 0.83004460 |
| 85 | STK38 | 0.81873010 |
| 86 | ITK | 0.81710872 |
| 87 | MAP3K14 | 0.80858345 |
| 88 | MAPK13 | 0.80182189 |
| 89 | RAF1 | 0.79855485 |
| 90 | MAP3K5 | 0.78870108 |
| 91 | MAP3K11 | 0.78359214 |
| 92 | DYRK3 | 0.77755972 |
| 93 | MATK | 0.77581898 |
| 94 | RPS6KB1 | 0.77502798 |
| 95 | ZAP70 | 0.75189517 |
| 96 | PKN2 | 0.72371827 |
| 97 | BMPR1B | 0.71880231 |
| 98 | JAK1 | 0.71543342 |
| 99 | PDK1 | 0.69300092 |
| 100 | SYK | 0.68603740 |
| 101 | HCK | 0.63948130 |
| 102 | ADRBK2 | 0.63770760 |
| 103 | DAPK1 | 0.63447125 |
| 104 | TRIM28 | 0.63309827 |
| 105 | UHMK1 | 0.62723671 |
| 106 | IKBKB | 0.62307771 |
| 107 | TTN | 0.61550557 |
| 108 | PRKCH | 0.61291018 |
| 109 | IRAK2 | 0.58123116 |
| 110 | PRKCE | 0.56997140 |
| 111 | PRKCG | 0.56192644 |
| 112 | PRKG2 | 0.55724672 |
| 113 | CCNB1 | 0.54962948 |
| 114 | * CDK14 | 0.54586389 |
| 115 | PIK3CG | 0.53689285 |
| 116 | LCK | 0.53380207 |
| 117 | RPS6KA2 | 0.52743736 |
| 118 | EPHB2 | 0.52633973 |
| 119 | TEC | 0.52543850 |
| 120 | MOS | 0.51858055 |
| 121 | DMPK | 0.51753882 |
| 122 | EGFR | 0.51042281 |
| 123 | WNK1 | 0.50955263 |
| 124 | TYRO3 | 0.50390085 |
| 125 | MAP2K7 | 0.49284223 |
| 126 | MUSK | 0.49056105 |
| 127 | PTK6 | 0.48334822 |
| 128 | ALK | 0.47890327 |
| 129 | SGK223 | 0.45846926 |
| 130 | SGK494 | 0.45846926 |
| 131 | CAMK2D | 0.45578471 |
| 132 | CAMK2A | 0.44899527 |
| 133 | CDK18 | 0.44811263 |
| 134 | TNK2 | 0.44639779 |
| 135 | BLK | 0.44161682 |
| 136 | PLK2 | 0.43983619 |
| 137 | CSK | 0.43432489 |
| 138 | LRRK2 | 0.42292728 |
| 139 | CDK15 | 0.42020643 |
| 140 | HIPK2 | 0.41471150 |
| 141 | MAPK15 | 0.40984558 |
| 142 | SGK3 | 0.40246133 |
| 143 | MAP3K10 | 0.40095628 |
| 144 | STK11 | 0.39378612 |
| 145 | NEK6 | 0.38731047 |
| 146 | OXSR1 | 0.38365856 |
| 147 | CLK1 | 0.37952780 |
| 148 | FES | 0.37838636 |
| 149 | BCR | 0.37510521 |
| 150 | JAK2 | 0.36884280 |
| 151 | LYN | 0.36524245 |
| 152 | TBK1 | 0.36205898 |
| 153 | PRKD1 | 0.35947721 |
| 154 | FGFR3 | 0.35370550 |
| 155 | MARK1 | 0.35015468 |
| 156 | MAP4K2 | 0.34508673 |
| 157 | GRK1 | 0.34260186 |
| 158 | TGFBR2 | 0.34013340 |
| 159 | PRKCZ | 0.33864078 |
| 160 | KIT | 0.33094953 |
| 161 | BRSK1 | 0.32653649 |
| 162 | TNIK | 0.32617452 |
| 163 | CDC42BPA | 0.31538715 |
| 164 | CDK11A | 0.31488947 |
| 165 | CSNK1D | 0.31310152 |
| 166 | MAP3K3 | 0.30757441 |
| 167 | EPHA3 | 0.30531286 |
| 168 | MAPK10 | 0.30276610 |
| 169 | PRKG1 | 0.29229473 |
| 170 | IRAK1 | 0.28950764 |
| 171 | FGR | 0.28395552 |
| 172 | MARK2 | 0.28290098 |
| 173 | SIK2 | 0.23101409 |
| 174 | CAMK4 | 0.21615626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.34802845 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.84514936 |
| 3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.66985696 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.60783133 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.57275114 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.46189276 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.33916554 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.24835780 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.23095071 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.19438593 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.12087632 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04754251 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03655982 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.00424658 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.99114880 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.91806052 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.91291235 |
| 18 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.90996496 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90378546 |
| 20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.87126552 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.82371081 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74271168 |
| 23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.73187493 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.73020940 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69121918 |
| 26 | GABAergic synapse_Homo sapiens_hsa04727 | 1.69023441 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68388917 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60090956 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53593029 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.53143251 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.52844876 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.52090366 |
| 33 | Morphine addiction_Homo sapiens_hsa05032 | 1.51999491 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51962812 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.51861351 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50454556 |
| 37 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.49948696 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49779264 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.49159139 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.46709899 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.45505704 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.44591520 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.42263537 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41856310 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40981903 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39804553 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39413200 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.37600166 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 1.37297333 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.36000128 |
| 51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.35798891 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31164589 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30279237 |
| 54 | Nicotine addiction_Homo sapiens_hsa05033 | 1.29278135 |
| 55 | Long-term depression_Homo sapiens_hsa04730 | 1.27333932 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24960519 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.21579342 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21556235 |
| 59 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20606153 |
| 60 | Measles_Homo sapiens_hsa05162 | 1.19476750 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18754145 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18565081 |
| 63 | Melanogenesis_Homo sapiens_hsa04916 | 1.18169969 |
| 64 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17286636 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15338062 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14694032 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10969246 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09449878 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08479270 |
| 70 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.08196282 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06842006 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05166941 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04834811 |
| 74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02744227 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02462889 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00843633 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99978064 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99673938 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99255959 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.98096182 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97255473 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.96435807 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94324618 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.93900832 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93423555 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93197876 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.92841721 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92379097 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90011884 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90008104 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89916064 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89079279 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87478961 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84382718 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84031188 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80205247 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79979946 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79507604 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.79160122 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.78006082 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77228287 |
| 102 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76392071 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75663795 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.75640253 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75423349 |
| 106 | RNA degradation_Homo sapiens_hsa03018 | 0.74828730 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74745052 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74261035 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.74162941 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73753554 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72575091 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71165156 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.70772651 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69536991 |
| 115 | Melanoma_Homo sapiens_hsa05218 | 0.68860168 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68639432 |
| 117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68108656 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67417192 |
| 119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66491564 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66489151 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66275612 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65887643 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65816327 |
| 124 | Axon guidance_Homo sapiens_hsa04360 | 0.64835882 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64712904 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63803154 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63688589 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62525627 |
| 129 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62435365 |
| 130 | Prion diseases_Homo sapiens_hsa05020 | 0.62240406 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61986277 |
| 132 | Adherens junction_Homo sapiens_hsa04520 | 0.61569238 |
| 133 | Malaria_Homo sapiens_hsa05144 | 0.60534936 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59825383 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.59660210 |
| 136 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59365287 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.58159351 |
| 138 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58133743 |
| 139 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.58072996 |
| 140 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56575337 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.55303891 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54246584 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53408300 |
| 144 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52715308 |
| 145 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51045825 |
| 146 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50803218 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49216095 |
| 148 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48636444 |
| 149 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47779106 |
| 150 | Alcoholism_Homo sapiens_hsa05034 | 0.47454380 |
| 151 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46777253 |
| 152 | Salmonella infection_Homo sapiens_hsa05132 | 0.45037276 |
| 153 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44126496 |
| 154 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42484516 |
| 155 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42347061 |
| 156 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42093103 |
| 157 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42025077 |
| 158 | Platelet activation_Homo sapiens_hsa04611 | 0.41129183 |
| 159 | Pertussis_Homo sapiens_hsa05133 | 0.39581920 |
| 160 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38811683 |

